AHA blog: Recent Study on Pandemic Funding Narrow and Incomplete

A recent JAMA-published study on U.S. hospitals’ financial performance during the COVID-19 public health emergency suffers from several methodological setbacks that undermine its credibility, writes Aaron Wesolowski, AHA’s vice president of policy, research, analytics and strategy. “Incomplete analyses like this are not reflective of the many immense struggles and challenges the hospital field has faced and continues to face, including a workforce shortage crisis, along with skyrocketing input costs for supplies, equipment, drugs and labor, and persistent inflation,” he concludes. “It is in everyone’s interest to keep hospitals strong and our patients healthy.” READ MORE
Related News Articles
Headline
Inova Health System’s Toni Ardabell, chief of clinical enterprise operations, and Sage Bolte, Ph.D., chief philanthropy officer and president of the Inova…
Headline
The Senate last night failed a fifth time to adopt the House-passed continuing resolution to fund the federal government, continuing the government shutdown.…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
Ashley Thompson, AHA senior vice president of public policy analysis and development, participated in a panel discussion during Modern Healthcare's Leadership…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…